title: Current treatment of neuromuscular diseases.
authors.affiliation: Department of Neurology, Robert C. Byrd Health Sciences Center of West Virginia University, G-103 Health Sciences North, PO Box 9180, Morgantown, WV 26506, USA.
authors.forename: L
authors.initials: L
authors.lastname: Kokontis
authors.forename: L
authors.initials: L
authors.lastname: Gutmann
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003882:Dermatomyositis / Q000276:immunology / Q000628:therapy; D020275:Guillain-Barre Syndrome / Q000276:immunology / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015624:Lambert-Eaton Myasthenic Syndrome / Q000276:immunology / Q000628:therapy; D016472:Motor Neuron Disease / Q000276:immunology / Q000628:therapy; D009157:Myasthenia Gravis / Q000276:immunology / Q000628:therapy; D009468:Neuromuscular Diseases / Q000276:immunology / Q000628:therapy*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000276:immunology / Q000628:therapy
chemical_list: D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents